Automateandvalidate a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced that it intends to offer and sell shares of its common stock, subject to market and other conditions, in an underwritten public offering.<a href="http://www.automateandvalidate.com">more information</a>